PlainRecalls
FDA Drug Moderate Class II Ongoing

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20

Reported: December 18, 2024 Initiated: November 19, 2024 #D-0136-2025

Product Description

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20

Reason for Recall

Subpotent and Superpotent Drug

Details

Recalling Firm
Mylan Institutional, Inc.
Units Affected
205 cartons
Distribution
Nationwide in the USA.
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20. Recalled by Mylan Institutional, Inc.. Units affected: 205 cartons.
Why was this product recalled?
Subpotent and Superpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2024. Severity: Moderate. Recall number: D-0136-2025.